New vaccine strategy targets SARS-CoV-2's stable S2 subunit, offering broad protection against evolving variants

Study presents a new SARS-CoV-2 S2 subunit vaccine that elicits strong antibody responses against various sarbecovirus strains, including challenging variants like XBB.1.5, demonstrating its potential as a broadly effective and stable vaccine option.

Related Keywords

,Human Embryonic Kidney ,Coronavirus Disease Covid 19 ,Cars ,Ars Cov 2 ,Vaccine ,Virus ,Ntibody ,Ntigen ,Fell ,Contamination ,Coronavirus ,Efficacy ,Electron ,Electron Microscopy ,Lisa ,Immune Response ,Kidney ,Icroscopy ,Utation ,Mycoplasma ,Protein ,Research ,Espiratory ,Evere Acute Respiratory ,Evere Acute Respiratory Syndrome ,Spike Protein ,Yndrome ,